111 related articles for article (PubMed ID: 16521343)
1. [Itraconazole capsules as antifungal prophylaxis for neutropenic patients with hematological malignancies from a single institution].
Toubai T; Tanaka J; Ota S; Kato N; Umehara S; Kahata K; Toyoshima N; Asaka M; Imamura M
Jpn J Antibiot; 2005 Dec; 58(6):507-17. PubMed ID: 16521343
[TBL] [Abstract][Full Text] [Related]
2. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
Lin R; Xu X; Li Y; Sun J; Fan Z; Jiang Q; Huang F; Zhou H; Nie D; Guo Z; Mao Y; Xiao Y; Liu Q
Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273
[TBL] [Abstract][Full Text] [Related]
3. [Significance of monitoring trough plasma concentration levels for invasive fungal infection prophylaxis with itraconazole oral solution in patients with hematological malignancies: a prospective study].
Kawano I; Matsumoto K; Jiromaru T; Jinnochi F; Semba Y; Sugio T; Sakamoto K; Saito N; Yoshida S; Henzan H; Takase K; Morita K; Eto T
Rinsho Ketsueki; 2016; 57(12):2475-2480. PubMed ID: 28090013
[TBL] [Abstract][Full Text] [Related]
4. [Effect of prophylaxis against myocosis in patients with hematological malignancy disease: efficacy of dosage of itraconazole].
Toubai T; Tanaka J; Fujisawa F; Kondo Y; Imamura M; Ota S; Hashino S; Yonetumi M; Chiba K; Kondo T; Toyoshima N; Asaka M
Jpn J Antibiot; 2003 Feb; 56(1):61-5. PubMed ID: 12723400
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole for invasive fungal infection with pediatric malignancies.
Kobayashi R; Suzuki D; Yasuda K; Kobayashi K
Pediatr Int; 2010 Oct; 52(5):707-10. PubMed ID: 20337979
[TBL] [Abstract][Full Text] [Related]
6. [Itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia].
Andrade M A; Puga L B; Guerra C C; Molina E J; Capurro C M
Rev Med Chil; 2011 Sep; 139(9):1128-34. PubMed ID: 22215390
[TBL] [Abstract][Full Text] [Related]
7. Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia.
Kaptan K; Ural AU; Cetin T; Avcu F; Beyan C; Yalçin A
J Infect Chemother; 2003 Mar; 9(1):40-5. PubMed ID: 12673406
[TBL] [Abstract][Full Text] [Related]
8. [Development of treatment adherence by jellification of itraconazole oral solution].
Wada H; Tanabe S; Ichikawa K; Sano F; Kubo Y; Matsuhashi Y; Nakanishi H; Tasaka T; Sugihara T
Jpn J Antibiot; 2009 Feb; 62(1):17-25. PubMed ID: 19378767
[TBL] [Abstract][Full Text] [Related]
9. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
[TBL] [Abstract][Full Text] [Related]
10. [Correlations between drug plasma concentration and adverse effects in patients treated with itraconazole for pulmonary aspergilloma].
Maesaki S; Hashiguchi K; Tomiyama Y; Sasaki E; Miyazaki H; Miyazaki Y; Higashiyama Y; Tomono K; Tashiro T; Kohno S
Nihon Kokyuki Gakkai Zasshi; 1999 Nov; 37(11):875-9. PubMed ID: 18217308
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of measuring the blood concentration of itraconazole oral solution in the field of hematology.
Shimoeda S; Nakagawa S; Kobayashi H; Yamato S; Kawano K; Ohta S
Biol Pharm Bull; 2010; 33(11):1861-6. PubMed ID: 21048312
[TBL] [Abstract][Full Text] [Related]
12. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Myoken Y; Sugata T; Kyo T; Fujihara M; Mikami Y
J Periodontol; 2002 Jan; 73(1):33-8. PubMed ID: 11846198
[TBL] [Abstract][Full Text] [Related]
13. Plasma Concentration of Itraconazole in Patients With Hematologic Malignancies Treated With Itraconazole Oral Solution.
Marumo A; Miyawaki S; Dan N; Ishiyama K
Ther Drug Monit; 2017 Jun; 39(3):229-234. PubMed ID: 28445212
[TBL] [Abstract][Full Text] [Related]
14. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
[TBL] [Abstract][Full Text] [Related]
15. Plasma itraconazole concentrations in patients with neutropenia: advantages of a divided daily dosage regimen.
Poirier JM; Hardy S; Isnard F; Tilleul P; Weissenburger J; Cheymol G
Ther Drug Monit; 1997 Oct; 19(5):525-9. PubMed ID: 9357095
[TBL] [Abstract][Full Text] [Related]
16. Antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia.
Glasmacher A; Molitor E; Hahn C; Bomba K; Ewig S; Leutner C; Wardelmann E; Schmidt-Wolf IG; Mezger J; Marklein G; Sauerbruch T
Leukemia; 1998 Sep; 12(9):1338-43. PubMed ID: 9737680
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of intravenous injecting itraconazole as empirical antifungal therapy for patients with hematological malignancies].
Luo CW; DU X; Guo R; Weng JY; Lu ZS; Wu SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):1000-4. PubMed ID: 22931672
[TBL] [Abstract][Full Text] [Related]
18. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
Tomioka H; Kaneda T; Kida Y; Kaneko M; Fujii H; Hayashi M; Tomii K; Tada K; Suzuki Y; Karino T
Kansenshogaku Zasshi; 2011 Nov; 85(6):644-51. PubMed ID: 22250455
[TBL] [Abstract][Full Text] [Related]
19. The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.
Kim JS; Cheong JW; Kim YK; Park J; Mun YC; Kang HJ; Yi HG; Lee JH; Kim YS; Ryoo HM; Kim SH; Kim HY; Kim JY; Lee DG; Kim HG; Kim H; Joo YD; Min YH
Ann Hematol; 2014 Jan; 93(1):33-42. PubMed ID: 23807252
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients.
Thunnissen PL; Sizoo W; Hendriks WD
Neth J Med; 1991 Aug; 39(1-2):84-91. PubMed ID: 1660108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
